Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications in Hematology
Treatment of Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma (Nhl) With Lisocabtagene Maraleucel in the Outpatient Setting: Results From Two Phase 2 Trials
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Tipifarnib in Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (Aitl) and Cxcl12+ Peripheral T-Cell Lymphoma (Ptcl): Preliminary Results From a Phase 2 Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Phase 2 Study of Parsaclisib (Incb050465) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (Dlbcl) (Citadel-202)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Deciphering the Contribution of Macrophages to Follicular Lymphoma Pathogenesis: New Insights Into Therapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Minimal Residual Disease (Mrd) in Early Stage Follicular Lymphoma Can Predict Prognosis and Drive Rituximab Treatment After Radiotherapy
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
The Role of Rituximab in Primary Central Nervous System Lymphoma (Pcnsl): A Systematic Review and Meta-Analysis
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Preliminary Results of a Phase II Study Using Response-Adapted Therapy for Limited-Stage Diffuse Large B-Cell Lymphoma Based on Interim PET/CT
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
BING NEEL SYNDROME: FIRST SUSPECT, THEN PROVE - A ROLE FOR CSF IgM ANALYSIS?
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Temozolomide in Relapse/Refractory Primary Vitreo-Retinal Lymphoma (R/R Pvrl): A Simple, Cheap, Effective and Well Tolerated Treatment. Result of the Largest Study on R/R Pvrl, From the Loc Network
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Hypogammaglobulinemia and Hypocomplementemia as Strong Prognostic Factors in Newly Diagnosed Diffuse Large B Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
‹
658
659
660
661
662
663
664
›
